News archive

Filter by: Reset

March 2022

- March 3, 2022
- MBL
MBL Donated 20,000 SARS-CoV-2 Antigen Test Kits to Ina City, Nagano Prefecture in Japan

MBL donated 20,000 their SARS-CoV-2 antigen test kits "GLINE-2019-nCoV Ag kit" to Ina City, Nagano Prefecture, where their research and production facilities are located

- February 11, 2022
- MBL
Acquisition of Manufacturing and Marketing Approval for SARS-CoV-2 Antigen Rapid Test and Release on 14th February

With a simple operation, the presence or absence of the SARS-CoV-2 antigen can be determined in 15 minutes

- January 26, 2022
- MBL
MBL Announces IVD Product Certification for MEBGEN AZF Deletion Kit for the Japanese Market

The kit is designed to detect the presence or absence of AZF deletion and the type of AZF deletion in Japanese men prior to microdissection testicular sperm extraction for male infertility
- January 19, 2022
- KBI Biopharma
Selexis and Inotrem Enter Service Agreement to Advance Inotrem’s Chronic Inflammatory Disease Program

Selexis and Inotrem have signed a service agreement to develop the cell line for Inotrem’s antibody-based candidate to address chronic inflammations
- January 18, 2022
- JSR Life Sciences
Aqualung Therapeutics Corp., an Immunotherapeutics Biotech Company, Closes a $2.5M Convertible Note Raise With a Comm...

Aqualung Therapeutics has closed a $2.5M convertible note fund raise led by a $1.5M investment from JSR Life Sciences, LLC
- January 12, 2022
- KBI Biopharma
Hemogenyx Pharmaceuticals and Selexis SA Will Advance Hemogenyx’s Acute Myeloid Leukemia (AML) CDX Bispecific Antibod...

Hemogenyx Pharmaceuticals will leverage Selexis’ SUREtechnology Platform™ of protein expression technologies and modular workflows

- December 8, 2021
- Crown Bioscience
Crown Bioscience Expands UK Facilities to Enable Growth of In Vivo Services

Upgraded facility increases capacity for in vivo services by 30 percent and adds high frequency ultrasound capabilities to the company’s preclinical capabilities
- December 7, 2021
- Crown Bioscience
Crown Bioscience Expands UK Facilities to Enable Growth of In Vivo Services

Upgraded facility increases capacity for in vivo services by 30 percent and adds high frequency ultrasound capabilities to the Company’s preclinical capabilities

- October 26, 2021
- Crown Bioscience
Crown Bioscience Unveils New Identity

The new brand reinforces the company’s commitment to the power of partnership and the infinite possibilities of scientific innovation
- October 11, 2021
- KBI Biopharma
KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

Companies will work together on critical components that can accelerate client-sponsored validation programs through downstream drug development
- October 7, 2021
- Crown Bioscience
Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology ...

Platform combining phenotypic high content imaging analysis and three-dimensional models of fresh patient tumors to provide relevant analysis of drug responses that can inform candidate selection a...
- October 7, 2021
- Crown Bioscience
Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology ...

Platform combining phenotypic high content imaging analysis and three-dimensional models of fresh patient tumors to provide relevant analysis of drug responses that can inform candidate selection a...

7 of 23